Clinical Trial Detail

NCT ID	NCT01803282
Title	Safety and Tolerability Study in Solid Tumors
Recruitment	Completed
Gender	both
Phase	Phase I
Variant Requirements	Yes
Sponsors	Gilead Sciences
Indications	lung non-small cell carcinoma gastric adenocarcinoma gastroesophageal junction adenocarcinoma Her2-receptor negative breast cancer colon adenocarcinoma pancreatic adenocarcinoma Advanced Solid Tumor rectum adenocarcinoma
Therapies	Andecaliximab Fluorouracil + Leucovorin + Oxaliplatin + Pembrolizumab Carboplatin + Pemetrexed Disodium Fluorouracil + Irinotecan + Leucovorin Gemcitabine + Nab-paclitaxel Carboplatin + Paclitaxel Paclitaxel Bevacizumab
Age Groups:	adult senior